Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 16.01
+0.32 (2.04%)
Oct 23, 2026, 3:00 PM CST
SHA:688276 Revenue
Changchun BCHT Biotechnology Co. had revenue of 157.16M CNY in the quarter ending June 30, 2026, with 28.19% growth. This brings the company's total for the last twelve months to 624.69M, down -30.25% year-over-year. In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 605.07M, down -50.77%. That makes Changchun BCHT Biotechnology Co. the 23,170th largest company in the world by revenue and 4,200th in China.
Revenue (ttm)
624.69M
Revenue Growth
-30.25%
P/S Ratio
10.60
Revenue / Employee
509.54K
Employees
1,226
Market Cap
6.62B
Revenue by Geography
- Eastern Region 247.02M 40.8%
- Southern Region 115.21M 19.0%
- Southwest 77.03M 12.7%
- Northwest 48.42M 8.0%
- Northeast 47.17M 7.8%
- Central China 46.82M 7.7%
- Foreign 15.46M 2.6%
- Northern Region 7.91M 1.3%
Fiscal year ended Dec 31, 2025 See the full SHA:688276 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 605.07M | -624.01M | -50.77% |
| Dec 31, 2024 | 1.23B | -595.60M | -32.64% |
| Dec 31, 2023 | 1.82B | 753.24M | 70.30% |
| Dec 31, 2022 | 1.07B | -130.58M | -10.86% |
| Dec 31, 2021 | 1.20B | -239.33M | -16.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.